Can Omega-3 and diet advice tame fatty liver disease?
NCT ID NCT06627114
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study investigates whether a nutrition education program and omega-3 supplements can help people with non-alcoholic fatty liver disease (NAFLD) lose weight, improve liver enzymes, and lower cholesterol. Participants are randomly assigned to receive nutrition guidance, omega-3 capsules, or standard care. The goal is to see if these simple interventions can reduce liver fat and improve overall health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- omega-3 fatty acids (DHA and EPA)
- What this could lead to
- If successful, this could offer a simple, low-cost way to manage non-alcoholic fatty liver disease through diet and supplements.
- What could go wrong
- This is a relatively small study, and results may not apply to everyone. Omega-3 supplements can cause mild side effects like fishy aftertaste or digestive issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hawler Medical University
Erbil, Kurdistan Region, 44001, Iraq
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 10-Year quest to uncover fatty Liver's hidden toll in china
- Can a promising NAFLD drug safely mix with other medicines? a trial seeks answers
- New ultrasound device could replace costly MRI for liver disease detection
- Bee product could tame fatty liver and blood fats
- Diabetes drugs may reverse fatty liver damage in new trial
- Automated blood test strategy could spot hidden liver disease in routine checkups